- BERBERINE ACID SULFATE
-
- $0.00 / 1kg
-
2026-04-02
- CAS:633-66-9
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
|
| | BERBERINE ACID SULFATE Basic information | | Uses |
| Product Name: | BERBERINE ACID SULFATE | | Synonyms: | berberine hydrogen sulphate;Berbamine sulphate acid;BERBERINE SULFATE(RG);BERBERINE SALTS/TENNATE
/HCL/B-SULPHATE/SULPHATE;berberinesulfate(1:1);siarczanuberberyny;Benzo[G]-1,3-benzodioxolo[5,6-A]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate;Benzo[G]-1,3-benzodioxolo[5,6-A]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (1:1) | | CAS: | 633-66-9 | | MF: | C20H19NO8S | | MW: | 433.43 | | EINECS: | 211-196-4 | | Product Categories: | Alkaloids;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 633-66-9.mol |  |
| | BERBERINE ACID SULFATE Chemical Properties |
| Melting point | 274-275 °C (decomp) | | storage temp. | Inert atmosphere,Room Temperature | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | color | White to yellow | | Stability: | Hygroscopic | | InChIKey | OJVABJMSSDUECT-UHFFFAOYSA-L | | SMILES | [O-]S([O-])(=O)=O.COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC.COc6ccc7cc8-c9cc%10OCOc%10cc9CC[n+]8cc7c6OC |
| Hazard Codes | Xn | | Risk Statements | 20/21/22 | | Safety Statements | 36 | | RIDADR | 1544 | | WGK Germany | 3 | | RTECS | DR9867000 | | HazardClass | 6.1(b) | | PackingGroup | III | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral |
| | BERBERINE ACID SULFATE Usage And Synthesis |
| Uses | Berberine Sulfate is an isoquinoline alkaloid with chemopreventative properties. It is used in the preparation of derivatives showing activity against leishmaniasis and malaria. | | Chemical Properties | Yellow needle-shaped crystals. Odorless, extremely bitter. MP 274°C. Soluble in water (1:30) and ethanol. | | Uses | Berberine Sulfate is an isoquinoline alkaloid with chemopreventative properties. It is used in the preparation of derivatives showing activity against leishmaniasis and malaria. | | in vivo | Berberine sulfate (10, 30, or 50 mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine at doses of 30 and 50 mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice[1]. | Animal Model: | 5-week-old BALB/c nu/nu mice with human colorectal adenocarcinoma LoVo xenografts[1] | | Dosage: | 10, 30, or 50 mg/kg/day | | Administration: | Gastrointestinal gavage; for 10 consecutive days | | Result: | Showed inhibitory rates of 33.1% and 45.3% at doses of 30 and 50 mg/kg/day.
|
|
| | BERBERINE ACID SULFATE Preparation Products And Raw materials |
|